Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-27 @ 4:49 AM
Study NCT ID:
NCT06450067
Status:
RECRUITING
Last Update Posted:
2024-09-19
First Post:
2024-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
Sponsor:
Juventas Cell Therapy Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06-05
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-03
First Submit QC Date:
None
Study First Post Date:
2024-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL